DEMURIS LIMITED
Significant control: Odyssey Therapeutics, Inc. (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Demuris Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Demuris Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
DEMURIS LIMITED is an active private limited company (company number 06255507) incorporated on 22 May 2007, registered in Kettering. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest full accounts cover the period ending 30 December 2024, showing net assets of £14k and cash of £69k, with 0 employees on average. Turnover was £13k and profit for the year £3,194.
By net assets it sits in the upper half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Odyssey Therapeutics, Inc.
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- can appoint or remove directors
- Mr Jeffery Errington
- owns 25–50% of shares
- Newcastle University Holdings Limited
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 22 May 200719 yrs ago
- Next accounts due
- 30 September 202625 days overdue
- Confirmation statement due
- 5 June 2027in 223 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 December 2024 | £14k | £69k | £5,280 | £60k | £13k | £3,194 | 0 |
| 31 December 2023 | — | — | — | — | — | — | — |
| 30 December 2023 | £11k | £168k | £5,828 | £163k | £92k | −£17k | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £14,211 at 30 December 2024
- Cash at bank of £50,000 or moreCash £69,131
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 22 May 2007
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 223 days
- Next accounts due25 days overdue
- Accounts period endNet assets £14k · full accounts
- Accounts period end
- Accounts period endNet assets £11k · full accounts
- Incorporated
Similar companies in Northampton
- AUSTIN DAVIS BIOLOGICS LTDKettering · inc. Apr 2009
- REAL WORLD DESIGNS LIMITEDNorthampton · inc. Apr 2003
- EKB PATH LIMITEDNorthampton · inc. Jun 2014
- CLINTREQ CONSULTANCY LTDNorthampton · inc. Apr 2015
- BLOOMSBURY CLINICAL RESEARCH LTDKettering · inc. Oct 2017
- LONGEVITY BIOTECH LTDTowcester · inc. Nov 2020
All companies incorporated on 22 May 2007 · in May 2007.
Reminders for DEMURIS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.